Shanghai Cohort Study of Diabetic Eye Disease
NCT03665090 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8000
Last updated 2018-09-11
Summary
To describe the design, methodology and baseline characteristics of the Shanghai Cohort study of Diabetic Eye disease (SCODE) study, a community-based study to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.
Conditions
- Diabetic Macular Edema of Both Eyes (Diagnosis)
- Diabetic Retinopathy Visually Threatening
Interventions
- BEHAVIORAL
-
Diabetic eye disease screening
Community-based, prospective cohort study from three consecutive years (2016 to 2018) to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.
Sponsors & Collaborators
-
Shanghai Eye Disease Prevention and Treatment Center
lead OTHER
Eligibility
- Min Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-01
- Primary Completion
- 2018-12-31
- Completion
- 2020-12-31
More Related Trials
-
Shanghai Children and Adolescent Diabetes Eye Study
NCT03587948 ·Status: RECRUITING
-
A Trial on Ophthalmologist-delivered Health Education on Top of Routine Community Care
NCT04490941 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema(DME)
NCT06908876 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
NCT00308542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Color Vision in Diabetic Patients
NCT03345667 ·Status: COMPLETED
-
Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
NCT02194634 ·Status: UNKNOWN ·Phase: PHASE3
-
Single-Cell Insights Into Diabetic Retinopathy Mechanisms
NCT06497608 ·Status: NOT_YET_RECRUITING
-
Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
NCT06478407 ·Status: RECRUITING
-
Study of Natural Course Progression of Diabetic Retinopathy
NCT06269419 ·Status: RECRUITING
-
Evaluation of Vitrectomy for Diabetic Macular Edema
NCT00709319 ·Status: COMPLETED
-
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
NCT06205979 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy
NCT03025399 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
NCT04292912 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy
NCT07236645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
NCT06198543 ·Status: NOT_YET_RECRUITING
-
Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
NCT00779142 ·Status: TERMINATED ·Phase: NA
-
Role of the Serum Exosomal miRNA in Diabetic Retinopathy (DR)
NCT03264976 ·Status: UNKNOWN
-
Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
NCT05759884 ·Status: UNKNOWN ·Phase: NA
-
Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
NCT01934920 ·Status: UNKNOWN
-
Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema
NCT04668703 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
Glycemic Control and Diabetic Macular Edema
NCT01358396 ·Status: COMPLETED
-
Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema
NCT06498050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography
NCT03240458 ·Status: UNKNOWN
-
Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
NCT02816710 ·Status: COMPLETED ·Phase: PHASE4